Monte Rosa Therapeutics
GLUE
#7011
Rank
NZ$0.75 B
Marketcap
$12.25
Share price
6.45%
Change (1 day)
34.32%
Change (1 year)

Monte Rosa Therapeutics (GLUE) - Total debt

Total debt on the balance sheet as of September 2024 : NZ$77.22 Million

According to Monte Rosa Therapeutics's latest financial reports the company's total debt is NZ$77.22 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Monte Rosa Therapeutics - Total debt on balance sheet (from 2021 to 2024)

Total debt by year

Year Total debt Change
2023-12-31NZ$72.8 M-1.66%
2022-12-31NZ$74.02 M
2021-12-31N/A
2019-12-31NZ$1.11 M